Regarding the patient who takes a 5-mg warfarin tablet five or six days a week and a half tablet the other days in order to reach a certain international normalized ratio (INR) Item 102-3), what ...

(Reuters) - Gene analysis failed in a U.S. clinical trial to help doctors select better doses of warfarin, the widely used blood-thinner, which can cause dangerous bleeding if doses are too high and ...

The antiphospholipid antibody syndrome is rare. Accordingly, it is remarkable that Crowther and his 19 partners [1] could devise a clinical trial involving 114 patients. The investigators discovered ...

Seattle, WA - Researchers in Seattle say they have uncovered specific genetic variations that influence how people respond to warfarin dose. Their study suggests that haplotypes of the VKORC1 gene can ...

One doctor offers answers to your questions about genetic testing and Coumadin. Aug. 17, 2007 — -- Thursday night on "World News," we asked for your questions regarding the new genetic testing ...

Coumadin (also known as Jantoven or warfarin) is a common medication used to prevent blood clots and strokes. Unlike many other drugs, however, it requires careful monitoring by the prescribing ...

Lower doses needed as renal function declines. Renal function plays a role in warfarin response, according to a study conducted at the University of Alabama in Birmingham. The study found that ...

(HealthDay News) — For warfarin-treated patients, carbamazepine co-treatment is associated with subtherapeutic anticoagulative effect and increased warfarin dose requirements, according to a study ...

BOSTON (Reuters) - Researchers have identified a new way to predict who is likely to develop dangerous bleeding or other serious reactions from taking the anticoagulant warfarin. Sign up here. They ...